new_0222_0240|PMVP|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0240|PMVP|Long Name|1|1|PMV Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|PMV Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|PMV Pharmaceuticals Inc Inventories (Quarterly) (USD)|PMV Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|PMV Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|PMV Pharmaceuticals Inc Book Value (Quarterly) (USD)|PMV Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|PMV Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|PMV Pharmaceuticals Inc EV to Revenues|PMV Pharmaceuticals Inc EV to Earnings|PMV Pharmaceuticals Inc EV to Free Cash Flow|PMV Pharmaceuticals Inc EV to Assets (Quarterly)|PMV Pharmaceuticals Inc PS Ratio|PMV Pharmaceuticals Inc PE Ratio|PMV Pharmaceuticals Inc Price to Book Value|PMV Pharmaceuticals Inc PEG Ratio|PMV Pharmaceuticals Inc Debt to Equity Ratio|PMV Pharmaceuticals Inc Dividend Yield|PMV Pharmaceuticals Inc Shareholder Yield (TTM)|PMV Pharmaceuticals Inc Percent of Shares Outstanding Short|PMV Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Payables (Quarterly) (USD)|PMV Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|PMV Pharmaceuticals Inc Return on Invested Capital|PMV Pharmaceuticals Inc Quality Ratio Score|PMV Pharmaceuticals Inc Momentum Score|PMV Pharmaceuticals Inc Beta (1Y)|PMV Pharmaceuticals Inc Sustainable Growth Rate (TTM)|PMV Pharmaceuticals Inc Institutional Investor Ownership Percentage|PMV Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|PMV Pharmaceuticals Inc Total Employees (Annual)|PMV Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|PMV Pharmaceuticals Inc Shares Outstanding|PMV Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|PMV Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|PMV Pharmaceuticals Inc Payout Ratio|PMV Pharmaceuticals Inc Quick Ratio (Quarterly)|PMV Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|PMV Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|PMV Pharmaceuticals Inc Effective Tax Rate (TTM)|PMV Pharmaceuticals Inc Return on Equity|PMV Pharmaceuticals Inc Net Income (TTM) (USD)|PMV Pharmaceuticals Inc Revenue (TTM) (USD)|PMV Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|PMV Pharmaceuticals Inc Revenue (Quarterly) (USD)|PMV Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|PMV Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|PMV Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|PMV Pharmaceuticals Inc Net Income (Quarterly) (USD)|PMV Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|PMV Pharmaceuticals Inc Price (USD)|PMV Pharmaceuticals Inc Total Return Price (USD)|PMV Pharmaceuticals Inc Enterprise Value (USD)|PMV Pharmaceuticals Inc 30-Day Average Daily Volume|PMV Pharmaceuticals Inc 1 Year Price Returns (Daily)
new_0222_0240|PMVP|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0240|PMVP||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0240|PMVP||5|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44839857651|0|0|0|1.44827586207|0|0|1.44827586207|0|15.25|0|106.5|106.5|0|0|30.6666666667|30.75|0|0|91.375|104|91.375|31.6923076923|0|106.5|0|0|91.375|91.25|91.4|0|91.4|0|0|0|0|91.375|91.375|91.375|91.375|1.44827586207|1.44827586207|1.44827586207|1.45141065831|1.42708333333
new_0222_0240|PMVP||6|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|281|0|0|0|348|0|0|348|0|32|0|6|6|0|0|3|4|0|0|8|1|8|13|0|6|0|0|8|4|5|0|5|0|0|0|0|8|8|8|8|348|348|348|319|96
new_0222_0240|PMVP||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0240|PMVP|201909|201909|201909||||||||||||||||||||||||||||||||||31.2343||-0.1977||||||-0.1977|||||||||1.545|-6.168|-6.175|0.272|||||
new_0222_0240|PMVP|201912|201912|201912|102.093|101.486||0.739||173.507|4.523|168.984||-70.474|-75.44|||||||||||||||2.837|0|||||||31.2343||-0.2256|||44.7737|||-0.2256|||||||||1.656|-7.047|-7.047|0.316|||||
new_0222_0240|PMVP|202003|202003|202003||||||||||||||||||||||||||||||||||31.2343||-0.2323||||||-0.2323|||||||||1.699|-7.253|-7.255|0.406|||||
new_0222_0240|PMVP|202006|202006|202006|156.757|156.106||0.609||5.147|5.053|0.094||153.895|-90.661|||||||||||||||2.146|0|||||||42.9993||-0.1853|||44.7737|||-0.1853||-0.0317||-28.444|||||2.281|-7.967|-7.967|0.157|||||
new_0222_0240|PMVP|202009|202009|202009|373.672|373.15||0.573||5.476|5.476|0||368.97|-99.426||||||||4.3078|||0||0.4175||0.548|0|||||||6.0225|39|-1.46|44.7737||44.7737|||-1.46|-224.541|-0.0161||-31.033|||||2.709|-8.761|-8.764|0.04|35.5|35.5|1216.3164||
new_0222_0240|PMVP|202010|202009|202009|||||||||||||||||||4.2532|||0||2.4233|||||||||||||||||||||||||||||||35.05|35.05|1196.1682||
new_0222_0240|PMVP|202011|202009|202009|||||||||||||||||||4.2763|||0||1.7796|||||||||83.5211||||44.7737||||||||||||||||||35.24|35.24|1204.6752|143256.9|
new_0222_0240|PMVP|202012|202012|202012|364.761|361.422||0.569||6.41|6.41|0||359.121|-109.88||||-72.7601||||7.6695|||0||4.0012||1.607|0|||||||44.7778|44|-0.2335|44.7778||44.7778|||-0.2335|1.365|-0.0174||-34.44|||||4.32|-10.453|-10.454|0.048|61.51|61.51|2392.8605|232234.8|
new_0222_0240|PMVP|202101|202012|202012|||||||||||||||-35.494||||4.2568|||0||3.5246|||||||||||||||||||||||||||||||34.14|34.14|1167.2921|203814.4667|
new_0222_0240|PMVP|202102|202012|202012|||||||||||||||-40.2459||||4.692|||0||3.8981|||||||||||||44.7826||||||||||||||||||37.63|37.63|1323.5666|91287.2667|
new_0222_0240|PMVP|202103|202103|202103|334.953|331.489||1.525||6.098|5.796|0.302||348.295|-121.482||||-30.3445||||4.2382|||0||6.2491||1.252|0|||||||44.7852||-0.26|44.8812||44.8812|||-0.26||-0.0206||-38.787|||||4.174|-11.598|-11.602|0.128|32.89|32.89|1144.6537|193591.5667|
new_0222_0240|PMVP|202104|202103|202103|||||||||||||||-31.3893||||4.3514|||0||7.5738|||||||||||||44.932||||||||||||||||||33.73|33.73|1184.0674|249603.1333|
new_0222_0240|PMVP|202105|202103|202103|||||||||||||||-32.2798||||4.4478|||0||7.6186|||||||||||||45.0334||||||||||||||||||34.4|34.4|1217.66|213157.4333|
new_0222_0240|PMVP|202106|202106|202106|323.08|318.349||12.016||18.063|7.504|10.559||337.847|-134.356||||-30.2506||||4.5716|||0||7.2009||2.369|0|||||||45.0701||-0.29|45.2136||45.2136|||-0.29||-0.0183||-43.694|||||5.386|-12.874|-12.874|0.113|34.16|34.16|1226.1476|365828.2667|
new_0222_0240|PMVP|202107|202106|202106|||||||||||||||-30.0833||||4.5515|||0||6.5402|||||||||||||||||||||||||||||||34.01|34.01|1219.3655|427684.5333|
new_0222_0240|PMVP|202108|202106|202106|||||||||||||||-26.0593||||4.0687|||0||6.2435|||||||||||||45.292||||||||||||||||||30.35|30.35|1056.2632|372446.7667|
new_0222_0240|PMVP|202109|202109|202109|313.555|307.651||11.804||19.23|8.563|10.667||324.948|-149.367||||-22.6928||||4.1591|||0||6.6475||1.278|0||||1.4691|||45.2952||-0.33|45.3522||45.3522|||-0.33|0|-0.0481||-49.941|||||5.935|-14.992|-15.011|0.102|29.8|29.8|1043.8446|414862.0667|-16.0563
new_0222_0240|PMVP|202110|202109|202109|||||||||||||||-16.5997||||3.2966|||0||6.3503||||||2|0.9434||||||||||||||||||||||||23.62|23.62|763.568|312258.2667|-32.5913
new_0222_0240|PMVP|202111|202109|202109|||||||||||||||-14.7693||||3.0375|||0||5.907||||||2|1.5956||||||45.3804||||||||||||||||||21.75|21.75|679.3727|316060.1333|-38.2804
new_0222_0240|PMVP|202112|202112|202112|||||||||||||||-16.1011||||3.226|||0||8.1602||||||2|0.5763||||||||||||||||||||||||23.1|23.1|740.6362|510045.5|-62.4451
new_0222_0240|PMVP|202201|202112|202112|||||||||||||||-9.1558||||2.2428|||0||12.1041||||||2|0.8067||||||||||||||||||||||||16.06|16.06|421.1582|652461.9|-52.9584
new_0222_0240|PMVP|202202|202112|202112|||||||||||||||-9.4025||||2.2778|||0|||||||||||||||||||||||||||||||||16.31|16.31|432.5033|614393.5667|-59.3165